Teva and Insilico partner on predictive biomanufacturing technology

Teva Pharmaceuticals and Insilico Biotechnology announced an agreement to apply Insilico's predictive biomanufacturing technology (Digital Twins) to create more efficient production processes for Teva's biopharmaceutical therapeutics.

“Teva will apply Insilico’s technology for predictive biomanufacturing to create more efficient biomanufacturing processes.”pharmtech.com

• 1 source
• pharmtech.comTeva, Insilico Partner on Predictive Biomanufacturing Technology | Pharmaceutical TechnologyFeb 21, 2019

Summarized from public sources; check the original articles before acting on it.